Nektar Therapeutics | Beneficio Operativo



Operating Profit Cambio Fecha
Agios Pharmaceuticals USD -106629000 18.41M 2025-03
ALKERMES USD 13.79M 148.9M 2025-03
Amgen USD 1.29B 1.02B 2025-03
Baxter International USD -435000000 590M 2024-12
Biogen USD 311.2M 130.2M 2025-03
Bristol-Myers Squibb USD 3.41B 2.62B 2025-03
Cipla INR 12.29B 4.8B 2025-03
Dr.Reddys Laboratories INR 15.43B 3.28B 2025-03
Eisai JPY -1024000000 28.59B 2025-03
Eli Lilly USD 5.41B 259.6M 2025-03
Exelixis USD 186.86M 23.65M 2025-04
Gilead Sciences USD 2.24B 215M 2025-03
GlaxoSmithKline GBP 2.22B 1.52B 2025-03
Grifols EUR 371.86M 54.83M 2024-12
Halozyme Therapeutics USD 141.54M 33.97M 2025-03
Incyte USD 205.17M 96.34M 2025-03
Ionis Pharmaceuticals USD -146000000 35.18M 2025-03
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
MacroGenics USD -16587000 70.78M 2024-12
Merck USD 5.87B 1.57B 2025-03
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 2.28B 1.34B 2024-12
Pfizer USD 3.67B 4.08B 2025-03
Roche Holding CHF 4.39B 1.04B 2024-12
Sarepta Therapeutics USD -300386000 462.07M 2025-03
Takeda JPY -74932000000 141.87B 2025-03
Teva Pharmaceutical Industries USD 519M 64M 2025-03
Xencor USD -43183000 47.23M 2025-03



Nektar Therapeutics Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jul 2025.